Multiple sclerosis linked to higher risk of mental illness during and after pregnancy
People with multiple sclerosis (MS) face a significantly higher risk of perinatal mental illness compared to those with other chronic conditions, according to a new study analyzing over 890,000 births in Ontario.
Women With Multiple Sclerosis Show Increased Migraine Risk Before Symptom Onset
Migraine may be a symptom of prodromal multiple sclerosis (MS), as the risk for migraine gradually increased closer to the onset of MS symptoms. Women with multiple sclerosis (MS) show increased risk for migraine for up to a decade prior to MS symptom onset, according to study results published in The Journal of Headache and Pain.
New Study Links Multiple Sclerosis to Increased Mental Health Risks During and After Pregnancy
A new study reveals that people with multiple sclerosis (MS) experience significantly higher rates of mental illness during pregnancy and the first year after childbirth, compared to those without MS.
Pregnancy raises risks to mental health in MS patients, study says
Overall, women with MS have a 26% increased risk of mental illness during pregnancy and a 33% increased risk after giving birth, compared to women without the degenerative nerve disease.
Pregnancy Increases Mental Health Risk in MS Patients
Pregnancy increases the risk of mental illness among women with multiple sclerosis (MS). Pregnant MS patients have a higher risk of mental illness both during gestation and in the first years after they give birth,
GlobalData on MSN19h
FDA adds boxed warning to multiple sclerosis drugs after anaphylaxis cases
Teva Pharmaceutical’s Copaxone was approved by the FDA in 1996 to treat relapsing forms of MS, an autoimmune disorder that ...
MedPage Today1d
FDA Warns About Anaphylaxis Risk With MS Drug
The FDA added a boxed warning about rare cases of anaphylaxis associated with the multiple sclerosis (MS) drug glatiramer ...
The American Journal of Managed Care1d
FDA Warns of Severe Allergic Reactions With Certain Multiple Sclerosis Drugs
The FDA issued a boxed warning for anaphylaxis risk linked to Glatiramer acetate and Glatopa, used in MS treatment.
HealthDay on MSN7h
Incidence, Prevalence of Peripartum Mental Illness Increased for Mothers With MS
Mothers with multiple sclerosis (MS) have an elevated incidence and prevalence of peripartum mental illness, accordi ...
FDA Warns Of Severe Allergic Reaction Risk With Teva's Multiple Sclerosis Drug
FDA issues new warnings about rare but severe allergic reactions, including anaphylaxis, linked to MS drug glatiramer acetate, urging immediate medical attention.
Healthline10d
Multiple Sclerosis (MS) Treatments
While there’s no cure for multiple sclerosis (MS), there are many treatments available. These treatments mainly focus on slowing down the progression of the disease and managing symptoms.
National Multiple Sclerosis Society Welcomes Stephanie Davidson and Lauren Hall to Leadership Team
The National Multiple Sclerosis Society, the leading global organization supporting and empowering people living with ...